Copyright: ©Author(s) 2026.
World J Nephrol. Jun 25, 2026; 15(2): 116524
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.116524
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.116524
Table 3 Comparison between the two groups for the preoperative, operative, and postoperative variables
| Variables | Group A (CU) | Group B (IC) | P value | |
| Age | 62 (48-83) | 61 (51-73) | 0.59 | |
| BMI (kg/m2) | 24.65 (19.2-29.5) | 23.15 (20.8-30.2) | 0.468 | |
| eGFR (ml/minute) | 88.5 (16-113) | 98.5 (48-117) | 0.287 | |
| Preoperative hemoglobin (g/dL) | 10.7 (9-14.7) | 12.85 (10.5-16.3) | 0.056 | |
| Preoperative serum creatinine (mg/dL) | 1 (0.5-3.9) | 0.85 (0.5-1.6) | 0.361 | |
| Smoking | 13 (81.25%) | 10 (62.5%) | 0.433 | |
| Medical comorbidities | 6 (37.5%) | 6 (37.5%) | > 0.999 | |
| Tumor stage | T1 | 5 (31.25%) | 3 (18.75%) | 0.445 |
| T2 | 5 (31.25%) | 12 (75%) | ||
| T3 | 6 (37.5%) | 1 (6.25%) | ||
| Tumor histopathology | Urothelial | 10 (62.5%) | 9 (56.25%) | 0.496 |
| Squamous cell carcinoma | 2 (12.5%) | 1 (6.25%) | ||
| Adenocarcinoma | 1 (6.3%) | 0 | ||
| Urothelial with variant | 3 (18.75%) | 6 (37.5%) | ||
| Neoadjuvant chemotherapy | 4 (25%) | 3 (18.75%) | > 0.999 | |
| Neoadjuvant radiotherapy | 2 (12.5%) | 0 | 0.484 | |
| Intravesical BCG | 3 (18.8%) | 1 (6.3%) | 0.6 | |
| Operative time (minutes) | 360 (250-480) | 350 (270-500) | 0.985 | |
| Shunt time (minutes) | 60 (40-110) | 122.5 (90-165) | < 0.001 | |
| Estimated blood loss (cc) | 950 (800-2000) | 900 (600-1600) | 0.171 | |
| Blood transfusion (units) | 2 (2-4) | 2 (1-4) | 0.184 | |
| Postoperative hemoglobin level (g/dL) | 10.15 (7.7-12.6) | 11.05 (8.9-13.6) | 0.029 | |
| Postoperative serum creatinine level (mg/dL) | 1.2 (0.6-3.3) | 1 (0.6-1.8) | 0.11 | |
| Hospital stay (days) | 10 (3-33) | 13 (9-55) | 0.08 | |
| Number of retrieved lymph nodes | 15.5 (4-28) | 20 (8-39) | 0.08 | |
| Perioperative complications | 15 (93.75%) | 16 (100%) | > 0.999 | |
| Complication grade | ||||
| No or low grades | 11 (68.75%) | 14 (87.5%) | 0.394 | |
| High grades | 5 (31.25%) | 2 (12.5%) | ||
| Days between appliance base changes | 15 (10-25) | 7 (5-15) | < 0.001 | |
| Serum creatinine level at last follow-up (mg/dL) | 1.15 (0.9-4.1) | 1.1 (0.8-2.2) | 0.12 | |
| eGFR (mL/minute) | 70 (14-100) | 78 (33-101) | 0.186 | |
| Incidence of re-intervention | 0.4 (0.699) | 0.46 (0.66) | > 0.999 | |
| Febrile UTI | 7 (63.63%) | 2 (14.28%) | 0.017 | |
| QoL score after 6 months | 68 (52-90) | 80.5 (62-103) | 0.029 | |
- Citation: Khalil M, Mahdy MH, Gadelkareem RA, Shahat A, Shalaby MA, Zarzour MA. Unilateral cutaneous ureterostomy with separate stomata vs ileal conduit after radical cystectomy. World J Nephrol 2026; 15(2): 116524
- URL: https://www.wjgnet.com/2220-6124/full/v15/i2/116524.htm
- DOI: https://dx.doi.org/10.5527/wjn.v15.i2.116524